Europe Drug Regulator's Advising Panel Recommends Approval Of Novo Nordisk's Australia-Approved Hemophilia Drug
Europe Drug Regulator's Advising Panel Recommends Approval Of Novo Nordisk's Australia-Approved Hemophilia Drug On Friday, Novo Nordisk A/S (NYSE:NVO) said that the European Medicines Agency’s (EMA...